NEWS AND PUBLICATIONS

Regulation of Biosimilars by ANVISA

Recently, the Brazilian Health Regulatory Agency (ANVISA) took a significant step by approving RDC No. 875 on May 28, 2024. This new regulation establishes for the registration of biosimilars in Brazil, marking an important milestone for the pharmaceutical industry....